Overview

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether marine omega-3 fatty acids and 5-alpha-reductase inhibitor are effective in the progression of prostate cancer for low-risk prostate cancer patients.

Phase:

N/A

Details

Lead Sponsor:

Centre Hospitalier Universitaire de Québec, CHU de Québec
CHU de Quebec-Universite Laval

Collaborators:

Prostate Cancer Canada
Prostate Cancer Canada Network

Treatments:

Dutasteride